Impact of changes of compnents of TH risk score on future prevalence of diabetes
Ended Purchase Order Awarded
- Contract number
- 75D30121P12238
- Awardee
-
Deutsche Diabetes Forschungsgesellschaft E.V UEI UDLYLLK1FBW4
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $178,519
Award facts
- Opportunity
-
- Impact of Changes of Components of the Risk Score on Future Prevalence of Diabetes with the Institute for Biometry and Epidemiology German Diabetes Center Pre-Solicitation · 75D30121Q73440 · Posted Jun 2, 2021
- Contract value 100% obligated
- $178,519.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AF11 Education, Training, Employment, & Social Svcs R&D Svcs; Education Svcs R&D; Basic Research
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Atlanta, GA 30341, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization, to provide research and modeling services related to the impact of changes in diabetes risk score components on future diabetes prevalence. The $178,519.19 contract, awarded on August 6, 2021, does not have a set-aside designation and is scheduled to conclude on August 31, 2022. Past similar awards to this vendor have funded mathematical modeling to forecast diabetes trends and assess the effects of risk factors, including the COVID-19 pandemic. The contract was awarded through a sole source process under the simplified acquisition procedures.
Quick answers
Who was awarded contract 75D30121P12238?
75D30121P12238 was awarded to Deutsche Diabetes Forschungsgesellschaft E.V by CDC Pittsburgh (Centers for Disease Control and Prevention) on August 6, 2021.
How much is contract 75D30121P12238 worth?
The government has obligated $178,519 on 75D30121P12238.
Was contract 75D30121P12238 competed?
The extent of competition for 75D30121P12238 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award